by Eileen Hoftyzer, University of Toronto Professors Stéphane Angers and Sachdev Sidhu pictured in the Donnelly Centre before the COVID-19 pandemic. Credit: University of Toronto The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy—a protein to treat disease. A century later, a new biologic therapy also...
With a San Francisco biotech company, an UdeM eye expert develops a treatment that could potentially treat patients who suffer from this degenerative disease of the retina. Potentially effective treatment for diabetic retinopathy, a disease that swells and scars the retina, has been developed by an Université de Montréal scientist and investigator at Maisonneuve-Rosemont Hospital Research Centre...
CREDIT: SEI KWANG HAHN (POSTECH) Diabetes is called an incurable disease because once it develops, it does not disappear regardless of treatment in modern medicine. Having diabetes means a life-long obligation of insulin shots and monitoring of blood glucose levels. But what if you could control the secretion of insulin just by wearing contact lenses?...
Results earn first FDA clearance of AI for autonomous detection of diabetic retinopathy UNIVERSITY OF IOWA HEALTH CARE A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary...
In oxygen-compromising conditions like diabetes, the body grows new blood vessels to help, but the result is often leaky, dysfunctional vessels that make bad matters worse. In oxygen-compromising conditions like diabetes, the body grows new blood vessels to help, but the result is often leaky, dysfunctional vessels that make bad matters worse. Now scientists...
(HealthDay)—The Runt-related transcription factor 1 (RUNX1) gene may play a role in human proliferative diabetic retinopathy (PDR), and upregulation may be a marker of aberrant retinal angiogenesis, according to a study published online April 11 in Diabetes. Noting that PDR affects those with type 1 and 2 diabetes, and is a common cause of blindness in...
